InMode Ltd.

Good day and welcome to InMode's first quarter 2026 earnings results conference call. All participants will be in listen-only mode. Should you need assistance, please signal a conference specialist by pressing the star key followed by zero. After today's presentation, there will be an opportunity to ask questions. To ask a question, you may press star then one on your telephone keypad. To withdraw your question, please press star then two. Please note this event is being recorded. I would now like to turn the conference over to Mary Siegel, CEO of MSIR. Please go ahead.

Thank you, operator, and everyone for joining us today. Welcome to InMode's conference call. Before we begin, I would like to remind our listeners that certain information provided on this call may contain forward-looking statements, and the safe harbor statement outlined in today's earnings release also pertains to this call. If you have not received the copy of the release, please go to the investor relations section of the company's website. Changes in business, competitive, technological, regulatory, and other factors could cause actual results to differ materially from those expressed by the forward-looking statements made today. Our historical results are not necessarily indicative of future performance. As such, we can give no assurance as to the accuracy of our forward-looking statements and assume no obligation to update them, except as required by law. With that, I'd like to pass the call over to Moshe Mizrachi, CEO. Moshe, please go ahead.

Thank you, Miri, and to everyone for joining us. With me today are Dr. Michael Crandall, our co-founder and chief technology officer, Yair Malka, our chief financial officer, and Mr. Mushik Itskovich, our Senior VP of Finance. Following our prepared remark, we will be available to answer your question. We executed in line with our expectation in Q1, 2026. In addition, we're seeing early sign of stabilization, particularly in the US. and believe that this quarter reinforced our confidence that 2026 is moving in the right direction. I would like to start by reviewing in-mode progress in North America. As you know, we brought in new leadership at the end of Q3 2025, including new North American President and Vice President. While it's still early, the energy and culture shift are already having positive impact. We have transitioned from our long-standing east-west structure to unify North American model, bringing Canada and both coasts under the same organization. This is driving better coordination and clearer accountability. We also implemented a key structure changes in January 1st, 2026. The Envision team, our ophthalmology and optometry sales force now operate independently. This create more focus model that we believe will support stronger execution over time. March deliver particularly strong progress, reinforcing our confidence that these changes are beginning to bear fruit. That said, we are looking for sustained consistency before calling it a long-term trend. On the international market, we continued to operate in over 100 countries, with most of our businesses driven by our direct sales to local offices and supported by distributive partnerships. Europe remains a strong region for us with solid performance and meaningful room for continued growth. In Asia, performance is more mixed, consistent with what we saw last year, though we are making progress in key markets, including China, where we see significant long-term potential. On the laser, The PCOR and the CO2 laser performed well recently, introduced a meaningful contribution to our Q1 revenue performance and are strategically important for our long-term growth. They expanded the range of procedures our physician can offer to enable combination of treatment, which are increasingly in demand. Physicians are looking for comprehensive solutions from a single partner, and these platforms support a one-stop-shop office. They may put pressure on our gross margin, but they play a critical role in strengthening our competitive position and deepening our customers' relationship. On the broader market environment, we are seeing sign of stabilization. Demand for static procedures was again pressured in the first quarter of 2026 by microeconomic headwind. But as we have said many times before, we believe that the demand for static procedure will not go away. It may be deferred, but it will return. Let me turn the call over to Yair, the Chief Financial Officer, who will talk to you, walk you through financial numbers. Yair.